NCT02138396 - Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Bioavailability

Interventions

DRUG

Fentanyl Sublingual Spray (FSS)

A single dose of fentanyl, 400 mcg per sublingual spray

DRUG

Fentanyl Citrate Injection (FCI)

A single dose of fentanyl citrate, 100 mcg per intramuscular injection

DRUG

Naltrexone

Naltrexone is provided as a 50 mg tablet before and after product dosing to minimize unacceptable adverse effects of fentanyl.

Trial Locations (1)

Worldwide Clinical Trials Early Phase Services, LLC, San Antonio